![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.262, 2000-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Maintenance pemetrexed too costly for NSCLC in China
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Routine screening for prevention of neonatal kernicterus too costly?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ECG screening for sudden death in athletes too costly for US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
TDF-based ART best, but too costly for resource-poor Lesotho?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Frequent gouty arthritis costly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. :